\
&
Contact us
\
&
Contact us
Besides Horizon 2020 and Horizon Europe there are many other relevant funding programmes managed by several agencies and directorates of the European Commission.
The Innovation Fund was set up with the revenues of the emission trading system (ETS). The purpose is to reduce greenhouse gas emissions by private companies in harder to abate sectors. It aims at 4 technologies: renewable energy sources and storage, carbon capture and storage, carbon capture and utilization, innovative low carbon solutions.
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
